European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 662-667 , June 2008

Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors

  • M.C. Jansen

      Affiliations

    • Department of Surgery, Academic Medical Center, Meibergdreef 9, 1109 AZ Amsterdam, the Netherlands
    • ,
  • S. van Wanrooy

      Affiliations

    • Department of Surgery, Academic Medical Center, Meibergdreef 9, 1109 AZ Amsterdam, the Netherlands
    • ,
  • R. van Hillegersberg

      Affiliations

    • Department of Surgery, Academic Medical Center Utrecht, Utrecht, the Netherlands
    • ,
  • A.M. Rijken

      Affiliations

    • Department of Surgery, Amphia Hospital, Breda, the Netherlands
    • ,
  • F. van Coevorden

      Affiliations

    • Department of Surgery, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, the Netherlands
    • ,
  • W. Prevoo

      Affiliations

    • Department of Radiology, Antoni van Leeuwenhoek, Netherland Cancer Institute, Amsterdam, the Netherlands
    • ,
  • T.M. van Gulik

      Affiliations

    • Department of Surgery, Academic Medical Center, Meibergdreef 9, 1109 AZ Amsterdam, the Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 5665570; fax: +31 20 6976621.

,Accepted 25 June 2007.

References 

  1. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19(1):59–71
  2. Fong Y, Blumgart LH. Hepatic colorectal metastasis: current status of surgical therapy. Oncology (Williston Park). 1998;12(10):1489–1498
  3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–1917
  4. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15(3):938–946
  5. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg. 1995;221(3):291–298
  6. Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137(12):1332–1339
  7. Curley SA, Izzo F, Ellis LM, Nicolas VJ, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232(3):381–391
  8. Jansen MC, van HR, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol. 2005;31(4):331–347
  9. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23(2):109–113
  10. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995;197(1):101–108
  11. Nikfarjam M, Christophi C. Interstitial laser thermotherapy for liver tumours. Br J Surg. 2003;90(9):1033–1047
  12. Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer. 1999;85(8):1694–1702
  13. Seifert JK, Stewart GJ, Hewitt PM, Bolton EJ, Junginger T, Morris DL. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg. 1999;23(10):1019–1026
  14. Seifert JK, France MP, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg. 2002;26(11):1333–1341
  15. Chapman WC, Debelak JP, Wright PC, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg. 2000;231(5):752–761
  16. Goldberg SN, Charboneau JW, Dodd GD, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228(2):335–345
  17. Green S, Weiss GR. Southwest oncology group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs. 1992;10(4):239–253
  18. Vadas P, Pruzanski W, Stefanski E, et al. Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action. Immunol Lett. 1991;28(3):187–193
  19. Wiersinga WJ, Jansen MC, Straatsburg IH, et al. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg. 2003;90(3):306–312
  20. Heinemann A, Wischhusen F, Puschel K, Rogiers X. Standard liver volume in the Caucasian population. Liver Transpl Surg. 1999;5(5):366–368
  21. Jansen MC, van Duijnhoven FH, van HR, et al. Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg. 2005;92(10):1248–1254
  22. Mutsaerts EL, van CF, Krause R, et al. Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands. Eur J Surg Oncol. 2003;29(9):731–734
  23. Schell SR, Wessels FJ, Abouhamze A, Moldawer LL, Copeland EM. Pro- and antiinflammatory cytokine production after radiofrequency ablation of unresectable hepatic tumors. J Am Coll Surg. 2002;195(6):774–781
  24. Teague BD, Court FG, Morrison CP, Kho M, Wemyss-Holden SA, Maddern GJ. Electrolytic liver ablation is not associated with evidence of a systemic inflammatory response syndrome. Br J Surg. 2004;91(2):178–183
  25. Ng KK, Lam CM, Poon RT, et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol. 2004;11(7):650–657
  26. Tranberg KG, Moller PH, Hannesson P, Stenram U. Interstitial laser treatment of malignant tumours: initial experience. Eur J Surg Oncol. 1996;22(1):47–54
  27. Wiezer MJ, Meijer C, Vuylsteke R, et al. Is major liver surgery associated with an increased systemic inflammatory response? A prospective comparison of hemihepatectomy and other major abdominal surgery. Liver. 1999;19(3):220–227
  28. de Jong KP, von Geusau BA, Rottier CA, et al. Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. J Hepatol. 2001;34(3):422–427

PII: S0748-7983(07)00270-3

doi: 10.1016/j.ejso.2007.06.009

European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 662-667 , June 2008

Article Tools

* Image Usage & Resolution